Innate Immune Response Regulation by the Human RNASET2 Tumor Suppressor Gene

The link between cancer development or progression and immune system dysregulation has long been established. Virtually every cell type belonging to both the innate and adaptive immune system has been reported to be involved in a complex interplay that might culminate into either a pro- or anti-tumo...

Full description

Bibliographic Details
Main Authors: Francesco Acquati, Lorenzo Mortara, Annarosaria De Vito, Denisa Baci, Adriana Albini, Marco Cippitelli, Roberto Taramelli, Douglas M. Noonan
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-11-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2019.02587/full
id doaj-c127aa4935bc400b9dfff8c89e8893ac
record_format Article
spelling doaj-c127aa4935bc400b9dfff8c89e8893ac2020-11-25T02:19:48ZengFrontiers Media S.A.Frontiers in Immunology1664-32242019-11-011010.3389/fimmu.2019.02587488255Innate Immune Response Regulation by the Human RNASET2 Tumor Suppressor GeneFrancesco Acquati0Lorenzo Mortara1Annarosaria De Vito2Denisa Baci3Adriana Albini4Adriana Albini5Marco Cippitelli6Roberto Taramelli7Douglas M. Noonan8Douglas M. Noonan9Human Genetics Laboratory, Department of Biotechnology and Molecular Sciences, University of Insubria, Varese, ItalyImmunology and General Pathology Laboratory, Department of Biotechnology and Life Sciences, University of Insubria, Varese, ItalyHuman Genetics Laboratory, Department of Biotechnology and Molecular Sciences, University of Insubria, Varese, ItalyImmunology and General Pathology Laboratory, Department of Biotechnology and Life Sciences, University of Insubria, Varese, ItalySchool of Medicine and Surgery, University of Milano-Bicocca, Monza, ItalyScientific and Technology Pole, IRCCS MultiMedica, Milan, ItalyDepartment of Molecular Medicine, Faculty of Pharmacy and Medicine, University La Sapienza, Rome, ItalyHuman Genetics Laboratory, Department of Biotechnology and Molecular Sciences, University of Insubria, Varese, ItalyImmunology and General Pathology Laboratory, Department of Biotechnology and Life Sciences, University of Insubria, Varese, ItalyScientific and Technology Pole, IRCCS MultiMedica, Milan, ItalyThe link between cancer development or progression and immune system dysregulation has long been established. Virtually every cell type belonging to both the innate and adaptive immune system has been reported to be involved in a complex interplay that might culminate into either a pro- or anti-tumorigenic response. Among the cellular components of the innate immune system, cells belonging to the monocyte/macrophage lineage have been consistently shown to play a key role in the tumorigenic process. The most advanced human tumors are reported to be strongly infiltrated with Tumor-Associated Macrophages (TAMs) endowed with the ability to contribute to tumor growth and dissemination. However, given their widely acknowledged functional plasticity, macrophages can display anti-tumor properties as well. Based on these premises, experimental approaches to promote the in vivo macrophage shift from pro-tumor to anti-tumor phenotype represent one of the most promising research field aimed at developing immune system-mediated tumor suppressive therapies. In this context, the human RNASET2 oncosuppressor gene has emerged as a potential tool for macrophage-mediated tumor suppression. A growing body of experimental evidence has been reported to suggest a role for this gene in the regulation of macrophage activity in both in vitro and in vivo experimental models. Moreover, several recent reports suggest a role for this gene in a broad range of cell types involved in immune response, pointing at RNASET2 as a putative regulator of several functional features within the immune system.https://www.frontiersin.org/article/10.3389/fimmu.2019.02587/fullT2 RNasesinnate immune responsetumor suppressionstress responsetumor microenvironmenttargeting immunotherapy
collection DOAJ
language English
format Article
sources DOAJ
author Francesco Acquati
Lorenzo Mortara
Annarosaria De Vito
Denisa Baci
Adriana Albini
Adriana Albini
Marco Cippitelli
Roberto Taramelli
Douglas M. Noonan
Douglas M. Noonan
spellingShingle Francesco Acquati
Lorenzo Mortara
Annarosaria De Vito
Denisa Baci
Adriana Albini
Adriana Albini
Marco Cippitelli
Roberto Taramelli
Douglas M. Noonan
Douglas M. Noonan
Innate Immune Response Regulation by the Human RNASET2 Tumor Suppressor Gene
Frontiers in Immunology
T2 RNases
innate immune response
tumor suppression
stress response
tumor microenvironment
targeting immunotherapy
author_facet Francesco Acquati
Lorenzo Mortara
Annarosaria De Vito
Denisa Baci
Adriana Albini
Adriana Albini
Marco Cippitelli
Roberto Taramelli
Douglas M. Noonan
Douglas M. Noonan
author_sort Francesco Acquati
title Innate Immune Response Regulation by the Human RNASET2 Tumor Suppressor Gene
title_short Innate Immune Response Regulation by the Human RNASET2 Tumor Suppressor Gene
title_full Innate Immune Response Regulation by the Human RNASET2 Tumor Suppressor Gene
title_fullStr Innate Immune Response Regulation by the Human RNASET2 Tumor Suppressor Gene
title_full_unstemmed Innate Immune Response Regulation by the Human RNASET2 Tumor Suppressor Gene
title_sort innate immune response regulation by the human rnaset2 tumor suppressor gene
publisher Frontiers Media S.A.
series Frontiers in Immunology
issn 1664-3224
publishDate 2019-11-01
description The link between cancer development or progression and immune system dysregulation has long been established. Virtually every cell type belonging to both the innate and adaptive immune system has been reported to be involved in a complex interplay that might culminate into either a pro- or anti-tumorigenic response. Among the cellular components of the innate immune system, cells belonging to the monocyte/macrophage lineage have been consistently shown to play a key role in the tumorigenic process. The most advanced human tumors are reported to be strongly infiltrated with Tumor-Associated Macrophages (TAMs) endowed with the ability to contribute to tumor growth and dissemination. However, given their widely acknowledged functional plasticity, macrophages can display anti-tumor properties as well. Based on these premises, experimental approaches to promote the in vivo macrophage shift from pro-tumor to anti-tumor phenotype represent one of the most promising research field aimed at developing immune system-mediated tumor suppressive therapies. In this context, the human RNASET2 oncosuppressor gene has emerged as a potential tool for macrophage-mediated tumor suppression. A growing body of experimental evidence has been reported to suggest a role for this gene in the regulation of macrophage activity in both in vitro and in vivo experimental models. Moreover, several recent reports suggest a role for this gene in a broad range of cell types involved in immune response, pointing at RNASET2 as a putative regulator of several functional features within the immune system.
topic T2 RNases
innate immune response
tumor suppression
stress response
tumor microenvironment
targeting immunotherapy
url https://www.frontiersin.org/article/10.3389/fimmu.2019.02587/full
work_keys_str_mv AT francescoacquati innateimmuneresponseregulationbythehumanrnaset2tumorsuppressorgene
AT lorenzomortara innateimmuneresponseregulationbythehumanrnaset2tumorsuppressorgene
AT annarosariadevito innateimmuneresponseregulationbythehumanrnaset2tumorsuppressorgene
AT denisabaci innateimmuneresponseregulationbythehumanrnaset2tumorsuppressorgene
AT adrianaalbini innateimmuneresponseregulationbythehumanrnaset2tumorsuppressorgene
AT adrianaalbini innateimmuneresponseregulationbythehumanrnaset2tumorsuppressorgene
AT marcocippitelli innateimmuneresponseregulationbythehumanrnaset2tumorsuppressorgene
AT robertotaramelli innateimmuneresponseregulationbythehumanrnaset2tumorsuppressorgene
AT douglasmnoonan innateimmuneresponseregulationbythehumanrnaset2tumorsuppressorgene
AT douglasmnoonan innateimmuneresponseregulationbythehumanrnaset2tumorsuppressorgene
_version_ 1724874244099145728